SC 13D Filing

Company

Ernexa Therapeutics Inc.

Filed

May 8, 2008

Accession Number

0001144204-08-027078

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →